Skip to content
Home/Companies/HealthTech/Instem
IN

Instem

HealthTech·US·Active·3yr hold

Instem is a healthcare it company, headquartered in United States.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Instem?

Instem is currently owned by ARCHIMED through MED Platform II (2022 vintage), since 2023.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED Platform II · 2022 · Buyout

Key facts

HQUnited States
SectorHealthcare IT

More from MED Platform II

Other portfolio companies in the same fund.

ARK Diagnostics
Active
MedTechUS· 2025
Symbio
Active
PharmaUS· 2023
WiQo
Active
HealthTechItaly· 2023
Corealis
Active
PharmaCanada· 2022
Natus
Active
MedTechUS· 2022

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

CIGA Healthcare
Active
Clarendon Fund ManagersUK
Paladin
Active
Ring CapitalFrance
Theraclion
Exited 2014
KaristaFrance
to
Access Infinity
Active
CBPE CapitalUK· 2026
Brightheart
Active
Odyssée VentureFrance· 2026
Dermascan
Active
Ring CapitalFrance· 2026
Data refreshed weekly · Sourced from public filings